Filing Details
- Accession Number:
- 0001543407-19-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-09 13:19:15
- Reporting Period:
- 2019-09-06
- Accepted Time:
- 2019-09-09 13:19:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1745188 | R Charles Bodner | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Svp Corp Fin Chief Acct Office | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-06 | 3,143 | $134.73 | 5,180 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-06 | 1,629 | $260.08 | 3,551 | No | 4 | D | Direct | |
Common Stock | Disposition | 2019-09-06 | 1,514 | $260.08 | 2,037 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2019-09-06 | 3,143 | $0.00 | 3,143 | $134.73 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2015-11-25 | 2024-11-25 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 67 | Indirect | By wife |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $260.00 through $260.46. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. This transaction was made pursuant to a 10b5-1 plan entered into on November 29, 2018.
- The stock appreciation rights vest in four annual installments beginning November 25, 2015.